tobramycin has been researched along with interleukin-8 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gosset, P; Husson, MO; Turck, D; Wallaert, B; Wizla-Derambure, N | 1 |
| Dudley, MN; Griffith, DC; Lomovskaya, O; Sabet, M; Tarazi, Z; Tsivkovskii, R | 1 |
| Bradbury, P; Kassiou, M; Ong, HX; Pozzoli, M; Reekie, TA; Robinson, PD; Sheikh, Z; Traini, D; Young, PM | 1 |
3 other study(ies) available for tobramycin and interleukin-8
| Article | Year |
|---|---|
Effect of intermittent inhaled tobramycin on sputum cytokine profiles in cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Adult; Cystic Fibrosis; Cytokines; Humans; Interleukin-6; Interleukin-8; Prospective Studies; Pseudomonas aeruginosa; Sputum; Tobramycin; Tumor Necrosis Factor-alpha | 2005 |
Levofloxacin reduces inflammatory cytokine levels in human bronchial epithelia cells: implications for aerosol MP-376 (levofloxacin solution for inhalation) treatment of chronic pulmonary infections.
Topics: Administration, Inhalation; Aerosols; Anti-Inflammatory Agents; Cell Line; Chronic Disease; Epithelial Cells; Gene Expression Profiling; Humans; Interleukin-6; Interleukin-8; Levofloxacin; Ofloxacin; Pneumonia; Tobramycin | 2011 |
Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Survival; Colistin; Cystic Fibrosis; Drug Combinations; Humans; Ibuprofen; Inflammation; Interleukin-8; Lipopolysaccharides; Pseudomonas aeruginosa; Tobramycin | 2021 |